Patents by Inventor Ruth E. McDermott

Ruth E. McDermott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing haloalkyl pyrimidines
    Publication number: 20040063938
    Abstract: The invention is a process for producing haloalkyl pyrimidines as intermediates in the production of benzimidazole and/or pyridylimidazole derivatives having high selectivity and/or high affinity to the benzodiazepine site of GABAA receptors.
    Type: Application
    Filed: June 10, 2003
    Publication date: April 1, 2004
    Applicant: Pfizer Inc
    Inventors: Stephane Caron, Nga M. Do, Ruth E. McDermott, Robert A. Singer
  • Hypoglycemic hydroxyurea derivatives
    Patent number: 5463070
    Abstract: Certain 1-(benzyl or 5-benzofuranylmethyl)-1-hydroxyurea derivatives are useful as hypoglycemic and hypocholesterolemic agents.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: October 31, 1995
    Assignee: Pfizer Inc.
    Inventors: Steven W. Goldstein, Ruth E. McDermott
  • Hypoglycemic hydroxyurea derivatives
    Patent number: 5334604
    Abstract: There are disclosed preparative processes and hypoglycemic compounds of the formula ##STR1## wherein R is hydrogen or C1 to C3 alkyl;R.sup.1 and R.sup.2 are taken together and are carbonyl; or R.sup.1 and R.sup.2 are taken separately, wherein R.sup.1 is hydrogen or R.sup.4 and R.sup.2 is--COR.sup.5 and COOR.sup.5 ;R.sup.3, R.sup.4 and R.sup.5 are each independently C1 to C9 alkyl, C3 to C7 cycloalkyl, phenyl, naphthyl, furyl, benzofuryl or thienyl or one of said groups mono- or disubstituted with C1 to C3 alkyl, C1 to C3 alkoxy, C1 to C3 alkoxy-carbonyl, trifluoromethyl, fluoro or chloro; and n is 0 or 1; or pharmaceutically acceptable cationic salts thereof.
    Type: Grant
    Filed: February 22, 1993
    Date of Patent: August 2, 1994
    Assignee: Pfizer Inc.
    Inventors: Steven W. Goldstein, Ruth E. McDermott